missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ S100A9 Monoclonal Antibody (CF-557), Biotin

Description
MA5-17625 targets Calgranulin B in FACS applications and shows reactivity with Human samples. The MA5-17625 immunogen is purified granulocyte antigen of human origin.
S100A9 (MRP-14) is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in the inhibition of casein kinase and altered expression of this protein is associated with the disease cystic fibrosis.
Specifications
Specifications
| Antigen | S100A9 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | CF-557 |
| Concentration | 0.1 mg/mL |
| Conjugate | Biotin |
| Formulation | PBS with 4-5mg/mL BSA and 0.02% sodium azide |
| Gene | S100A9 |
| Gene Accession No. | P06702 |
| Gene Alias | 60B8AG; AW546964; BEE22; BM-009; Cagb; calgranulin B; calgranulin-B; Calprotectin L1H subunit; CFAG; CGLB; DKFZp686B04128; GAGB; intracellular calcium-binding protein (MRP14); L1AG; Leukocyte L1 complex heavy chain; LIAG; MAC387; Macrophage; MIF; Migration inhibitory factor-related protein 14; Monocyte; MRP14; MRP-14; MRP15; MRP16; myeloid-related protein 14; NIF; P14; protein S100-A9; S100 A9; S100 calcium binding protein A9; S100 calcium binding protein A9 (calgranulin B); S100 calcium-binding protein A9; S100 calcium-binding protein A9 (calgranulin B); S100a9 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?